128 related articles for article (PubMed ID: 28212737)
1. Gene delivery of apoptin-derived peptide using an adeno-associated virus vector inhibits glioma and prolongs animal survival.
Zhong X; Zhao H; Liang S; Zhou D; Zhang W; Yuan L
Biochem Biophys Res Commun; 2017 Jan; 482(3):506-513. PubMed ID: 28212737
[TBL] [Abstract][Full Text] [Related]
2. Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma.
Crommentuijn MH; Maguire CA; Niers JM; Vandertop WP; Badr CE; Würdinger T; Tannous BA
Mol Oncol; 2016 Apr; 10(4):625-34. PubMed ID: 26708508
[TBL] [Abstract][Full Text] [Related]
3. A peptide derived from apoptin inhibits glioma growth.
Zhang L; Zhao H; Cui Z; Lv Y; Zhang W; Ma X; Zhang J; Sun B; Zhou D; Yuan L
Oncotarget; 2017 May; 8(19):31119-31132. PubMed ID: 28415709
[TBL] [Abstract][Full Text] [Related]
4. Systemic AAV9-IFNβ gene delivery treats highly invasive glioblastoma.
GuhaSarkar D; Su Q; Gao G; Sena-Esteves M
Neuro Oncol; 2016 Nov; 18(11):1508-1518. PubMed ID: 27194146
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral decorin gene delivery by AAV vector inhibits brain glioblastomas and prolongs survival of animals by inducing cell differentiation.
Ma HI; Hueng DY; Shui HA; Han JM; Wang CH; Lai YH; Cheng SY; Xiao X; Chen MT; Yang YP
Int J Mol Sci; 2014 Mar; 15(3):4393-414. PubMed ID: 24625664
[TBL] [Abstract][Full Text] [Related]
6. Intracranial AAV-IFN-β gene therapy eliminates invasive xenograft glioblastoma and improves survival in orthotopic syngeneic murine model.
GuhaSarkar D; Neiswender J; Su Q; Gao G; Sena-Esteves M
Mol Oncol; 2017 Feb; 11(2):180-193. PubMed ID: 28098415
[TBL] [Abstract][Full Text] [Related]
7. Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma.
Thorsen F; Afione S; Huszthy PC; Tysnes BB; Svendsen A; Bjerkvig R; Kotin RM; Lønning PE; Hoover F
J Gene Med; 2006 Sep; 8(9):1131-40. PubMed ID: 16810631
[TBL] [Abstract][Full Text] [Related]
8. Nonviral gene therapy in vivo with PAM-RG4/apoptin as a potential brain tumor therapeutic.
An S; Nam K; Choi S; Bai CZ; Lee Y; Park JS
Int J Nanomedicine; 2013; 8():821-34. PubMed ID: 23589689
[TBL] [Abstract][Full Text] [Related]
9. Suppression of intracranial human glioma growth after intramuscular administration of an adeno-associated viral vector expressing angiostatin.
Ma HI; Guo P; Li J; Lin SZ; Chiang YH; Xiao X; Cheng SY
Cancer Res; 2002 Feb; 62(3):756-63. PubMed ID: 11830530
[TBL] [Abstract][Full Text] [Related]
10. Apoptin Gene Delivery by the Functionalized Polyamidoamine Dendrimer Derivatives Induces Cell Death of U87-MG Glioblastoma Cells.
Bae Y; Rhim HS; Lee S; Ko KS; Han J; Choi JS
J Pharm Sci; 2017 Jun; 106(6):1618-1633. PubMed ID: 28188727
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of systemic temozolomide-activated phage-targeted gene therapy in human glioblastoma.
Przystal JM; Waramit S; Pranjol MZI; Yan W; Chu G; Chongchai A; Samarth G; Olaciregui NG; Tabatabai G; Carcaboso AM; Aboagye EO; Suwan K; Hajitou A
EMBO Mol Med; 2019 Apr; 11(4):. PubMed ID: 30808679
[TBL] [Abstract][Full Text] [Related]
12. Development of next generation adeno-associated viral vectors capable of selective tropism and efficient gene delivery.
Zhang C; Yao T; Zheng Y; Li Z; Zhang Q; Zhang L; Zhou D
Biomaterials; 2016 Feb; 80():134-145. PubMed ID: 26708090
[TBL] [Abstract][Full Text] [Related]
13. [Construction and identification of recombinant adeno-associated virus vector harboring fusion gene NT4-Apoptin-HA2-TAT].
Wang JS; Zhang MX; Liu DC; Duan XY; Zhou SN; Zhang GJ; Yang GX; Wang QY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Aug; 24(8):754-6. PubMed ID: 18687210
[TBL] [Abstract][Full Text] [Related]
14. Controlling brain tumor growth by intraventricular administration of an AAV vector encoding IFN-beta.
Meijer DH; Maguire CA; LeRoy SG; Sena-Esteves M
Cancer Gene Ther; 2009 Aug; 16(8):664-71. PubMed ID: 19197327
[TBL] [Abstract][Full Text] [Related]
15. Genetic modification of neurons to express bevacizumab for local anti-angiogenesis treatment of glioblastoma.
Hicks MJ; Funato K; Wang L; Aronowitz E; Dyke JP; Ballon DJ; Havlicek DF; Frenk EZ; De BP; Chiuchiolo MJ; Sondhi D; Hackett NR; Kaminsky SM; Tabar V; Crystal RG
Cancer Gene Ther; 2015 Jan; 22(1):1-8. PubMed ID: 25501993
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of a recombinant pseudotype baculovirus expressing Apoptin in vitro and in vivo.
Pan Y; Fang L; Fan H; Luo R; Zhao Q; Chen H; Xiao S
Int J Cancer; 2010 Jun; 126(11):2741-51. PubMed ID: 19824041
[TBL] [Abstract][Full Text] [Related]
17. Widespread dispersion of adeno-associated virus serotype 1 and adeno-associated virus serotype 6 vectors in the rat central nervous system and in human glioblastoma multiforme xenografts.
Huszthy PC; Svendsen A; Wilson JM; Kotin RM; Lønning PE; Bjerkvig R; Hoover F
Hum Gene Ther; 2005 Mar; 16(3):381-92. PubMed ID: 15812233
[TBL] [Abstract][Full Text] [Related]
18. Anti-Epidermal Growth Factor Receptor Gene Therapy for Glioblastoma.
Hicks MJ; Chiuchiolo MJ; Ballon D; Dyke JP; Aronowitz E; Funato K; Tabar V; Havlicek D; Fan F; Sondhi D; Kaminsky SM; Crystal RG
PLoS One; 2016; 11(10):e0162978. PubMed ID: 27711187
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma.
Liu L; Wu W; Zhu G; Liu L; Guan G; Li X; Jin N; Chi B
Int J Mol Med; 2012 Oct; 30(4):747-54. PubMed ID: 22842823
[TBL] [Abstract][Full Text] [Related]
20. Systemic delivery of lentivirus-mediated secretable TAT-apoptin eradicates hepatocellular carcinoma xenografts in nude mice.
Ma JL; Han SX; Zhao J; Zhang D; Wang L; Li YD; Zhu Q
Int J Oncol; 2012 Sep; 41(3):1013-20. PubMed ID: 22767069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
